Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

New England Journal of Medicine

Volumn 351, Issue 21, 2004, Pages 2159-2169

  Dave, Sandeep S ^a,c   Wright, George ^a   Tan, Bruce ^a   Rosenwald, Andreas ^a,m   Gascoyne, Randy D ^d   Chan, Wing C ^e   Fisher, Richard I ^f,g   Braziel, Rita M ^h   Rimsza, Lisa M ⁱ   Grogan, Thomas M ^f,i   Miller, Thomas P ^f,i   LeBlanc, Michael ^f,j   Greiner, Timothy C ^e   Weisenburger, Dennis D ^e   Lynch, James C ^e   Vose, Julie ^e   Armitage, James O ^e   Smeland, Erlend B ^k   Kvaloy, Stein ^k   Holte, Harald ^k   Delabie, Jan ^k   Connors, Joseph M ^d   Lansdorp, Peter M ^d   Ouyang, Qin ^d   Lister, T Andrew ^l   Davies, Andrew J ^l   Norton, Andrew J ^l   Muller Hermelink, H Konrad ^m   Ott, German ^m   Campo, Elias ⁿ   Montserrat, Emilio ⁿ   Wilson, Wyndham H ^a   Jaffe, Elaine S ^a   Simon, Richard ^a   Yang, Liming ^b   Powell, John ^b   Zhao, Hong ^a   Goldschmidt, Neta ^a   Chiorazzi, Michael ^a   Staudt, Louis M ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f Southwest Oncology Group   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ARIZONA   (United States)

^j Fred Hutchinson Cancer Research Center   (United States)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^m UNIVERSITY OF WÜRZBURG   (Germany)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DENDRITIC CELLS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, FOLLICULAR; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 8644252736     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041869     Document Type: Article

References (30)

1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol 1998;16:2780-95.
2. Horning SJ. Follicular lymphoma: have we made any progress? Ann Oncol 2000;11:Suppl 1:23-7.
3. Johnson PW, Rohatiner AZ, Whelan JS, et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995;13:140-7.
4. Czuczman MS, Grillo-Lopez AT, White CA, et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999;17:268-76.
5. Colombat P, Salles G, Brousse N, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 2001;97:101-6.
6. Witzig TE, Gordon LI, Cabanillas F, et al. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B cell non-Hodgkin's lymphoma. J Clin Oncol 2002;20:2453-63.
7. Maloney DG, Grillo-Lopez AT, White CA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997;90:2188-95.
8. Bendandi M, Gocke CD, Kobrin CB, et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med 1999;5:1171-7.
9. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 1992;327:1209-15.
10. Timmerman JM, Czerwinski DK, Davis TA, et al. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002;99:1517-26.
11. Lossos IS, Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 2003;13:191-202.
12. Federico M, Vitolo U, Zinzani PL, et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 2000;95:783-9.
13. Lopez-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994;12:1343-8.
14. Montoto S, Lopez-Guillermo A, Ferrer A, et al. Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol 2002;13:523-30.
15. Decaudin D, Lepage E, Brousse N, et al. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients - a study of the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1999;17:2499-505.
16. Solal-Celigny P, Roy P, Colombat P, et al. Follicular Lymphoma International Prognostic Index. Blood 2004;104:1258-65.
17. Alizadeh AA, Eisen MB, Davis RB, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
18. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
19. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
20. Shaffer AL, Rosenwald A, Hurt EM, et al. Signatures of the immune response. Immunity 2001;15:375-85.
21. Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309-14.
22. Drapner NS, Smith H. Applied regression analysis. New York: Wiley, 1966.
23. Li DN, Matthews SP, Antoniou AN, Mazzeo D, Watts C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J Biol Chem 2003;278:38980-90.
24. Sui L, Zhang W, Liu Q, et al. Cloning and functional characterization of human septin 10, a novel member of septin family cloned from dendritic cells. Biochem Biophys Res Commun 2003;304:393-8.
25. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-103.
26. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998-6004.
27. Roglic A, Prossnitz ER, Cavanagh SL, Pan Z, Zou A, Ye RD. cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure. Biochim Biophys Acta 1996;1305:39-43.
28. Ames RS, Li Y, Sarau HM, et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 1996;271:20231-4.
29. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984;311:1471-5.
30. Bohen SP, Troyanskaya OG, Alter O, et al. Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A 2003;100:1926-30.